Two years after its initial approval, the CRISPR-based sickle-cell cure Casgevy has been made available in 30 countries through a landmark access agreement between Vertex Pharmaceuticals, the WHO, and the African Union. The therapy, which edits a patient's own stem cells to produce healthy hemoglobin, has cured over 4,500 patients so far with a single treatment.
"No child should suffer from a disease we know how to cure," said WHO Director-General Dr. Tedros Adhanom Ghebreyesus. Under the agreement, the treatment cost has been reduced by 90% in low-income countries. Mobile treatment centres are being deployed across sub-Saharan Africa, bringing the therapy to rural communities where sickle-cell disease affects up to 3% of newborns. Early data shows 97% of treated patients remain symptom-free after one year.
“The therapy, which edits a patient's own stem cells to produce healthy hemoglobin, has cured over 4,500 patients so far with a single treatment.”
How did this story make you feel?
📎 Cite this article
Good News Good Vibes. (2026, February 20). CRISPR Sickle-Cell Cure Now Available in 30 Countries After WHO-Backed Rollout. Retrieved from https://goodnewsgoodvibes.com/en/article/crispr-sickle-cell-cure-global-rollout
https://goodnewsgoodvibes.com/en/article/crispr-sickle-cell-cure-global-rollout
Editorial Team
Our editorial team curates and verifies positive news from credible sources worldwide.
Last reviewed: February 20, 2026
Trending
LHCb Collaboration Discovers New Proton-Like Particle with Two Charm Quarks
Science · 5 min
Johannes Høsflot Klæbo Wins Six Golds at 2026 Winter Olympics — New Record
Sports · 4 min
Renewables Overtake Coal as World's Top Electricity Source for First Time
Environment · 5 min
Shingles Vaccine Cuts Risk of Major Cardiac Events by 46%, Landmark Study Finds
Health · 5 min
Monarch Butterfly Population Surges 64% in Mexico Overwintering Season
Animals · 4 min
